| Document |
Document Title |
|
WO/2002/089128A1 |
An optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer A b s t r a c tAn optical data storage medium containing a preferably transparent substrate which has optionally a...
|
|
WO/2002/086879A1 |
The invention relates to an optical data support, comprising a preferably transparent substrate, optionally already coated with one or several reflective layers, with an information layer, which may be written to by means of light, optio...
|
|
WO/2002/086472A1 |
The present invention concerns the development and use of fluorescent dyes known as molecular rotors which vary in fluorescence intensity based on viscosity of the environment. The inventor further relates to a class of molecular motors ...
|
|
WO/2002/086878A2 |
The invention relates to an optical data carrier containing a preferably transparent substrate that is optionally already coated with a reflecting layer. An information layer, which can be written with light, optionally, a reflecting lay...
|
|
WO/2002/085886A2 |
This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceut...
|
|
WO/2002/084656A1 |
The invention relates to an optical data carrier that contains a preferably transparent substrate that is optionally already coated with one or more reflective layers, onto whose surface an information layer which can be written on with ...
|
|
WO/2002/079691A1 |
The present invention provides compounds and compositions, which include: at least one chromophore having strong simultaneous two-photon or multi-photon absorptivity; at least one acid- or radical-generator in close proximity to the chro...
|
|
WO/2002/080152A2 |
The invention relates to an optical data carrier that contains a preferably transparent substrate that is optionally already coated with one or more reflective layers, onto whose surface an information layer which can be written on with ...
|
|
WO/2002/080150A2 |
Optical data medium containing a preferably transparent substrate which is optionally already coated with one or more barrier layers and on the surface of which an information layer which can be recorded on using light, optionally one or...
|
|
WO/2002/080161A2 |
The invention relates to an optical data carrier that contains a preferably transparent substrate that is optionally already coated with one or more reflective layers, onto whose surface an information layer which can be written on with ...
|
|
WO/2002/080162A1 |
The invention relates to optical data memories containing a preferably transparent substrate that is optionally already coated with one or more reflective layers. An information layer that can be written with light, optionally, one or mo...
|
|
WO/2002/080159A1 |
The invention relates to an optical data carrier that contains a preferably transparent substrate that is optionally already coated with one or more reflective layers, onto whose surface an information layer which can be written on with ...
|
|
WO/2002/080163A1 |
The invention relates to an optical data carrier containing a preferably transparent substrate that is optionally already coated with a protective layer already. An information layer that can be written using light, an optional protectiv...
|
|
WO/2002/080160A1 |
The invention relates to an optical data carrier that contains a preferably transparent substrate that is optionally already coated with one or more reflective layers, onto whose surface an information layer which can be written on with ...
|
|
WO/2002/077984A1 |
The invention relates to an optical data carrier containing a preferably transparent substrate which has optionally been coated with at least one reflection layer. An information layer which can be written with light, optionally at least...
|
|
WO/2002/057265A1 |
Provided are compounds capable of inhibiting the production of inflammatory cytokines, more specifically compounds represented by the general formula (|) or pharmacologically acceptable salts, esters or other derivatives thereof: (|) whe...
|
|
WO/2002/057254A1 |
Compositions for prevention or treatment of hepatopathy, containing as the active ingredient compounds represented by the general formula (I), or pharmaceutically acceptable salts, ester, or other derivatives thereof: (I) wherein A is a ...
|
|
WO/2002/053543A1 |
A compound having an affinity for a cannabinoid 2-type receptor. It is represented by the formula (I): (I) wherein R?1¿ represents a group represented by the formula -Y?1¿-Y?2¿-Y?3¿-Ra (wherein Y?1¿ is a single bond, etc.; Y?2¿ is ...
|
|
WO/2002/048138A1 |
Compounds of formula (I) are effective antimicrobial agents.
|
|
WO/2002/048143A2 |
Compounds having the general structure (Formula) are effective antimicrobial agents.
|
|
WO/2002/025648A1 |
The invention relates to an optical data carrier containing a preferably transparent substrate which is optionally coated with one or more reflecting layers. A light-inscribable information layer and optionally one or more reflecting lay...
|
|
WO/2002/025205A1 |
The invention relates to an optical data support which can be written once, to the use of co-phthalocyanin complexes as light-absorbing compounds in the optically writable information layer of optical data supports, especially for CD-Rs,...
|
|
WO/2002/024695A2 |
The invention features substituted fused bicyclic compounds, pharmaceutical compositions containing them, and methods of using them to treat or prevent histamine-mediated diseases and conditions.
|
|
WO/2002/024696A1 |
A process for easily and industrially advantageously producing both a tricyclic fused heterocyclic derivative having acetylcholinesterase inhibitory activity and an intermediate for the derivative. The process for producing the target co...
|
|
WO/2002/022614A1 |
Compounds of the general formula (I), esters of the same, or pharmacologically acceptable salts thereof, useful as synthetic antimicrobial agents, wherein R?1¿ is hydrogen, alkyl, or the like; R?2¿ is hydrogen, alkyl, C¿1-6? alkoxy, o...
|
|
WO/2002/020485A1 |
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formula (Ia) and (Ib) where R¿2?, R¿3?, R¿4?, R¿5?, R¿6?, R¿7?, R¿8?, Het and X are defined herein. The compounds are useful for treating autoim...
|
|
WO/2002/009758A2 |
Compounds are described which are efflux pump inhibitors of cellular efflux pumps of microbes. Also described are methods of preparing such compounds, methods of using such efflux pump inhibitor compounds and pharmaceutical compositions ...
|
|
WO/2002/008475A2 |
The present invention relates generally to a process for recovering copper and other metal values from metal-containing materials using controlled, super-fine grinding reducing the particle size to less than 25 micrometer and medium temp...
|
|
WO/2002/004445A1 |
The present invention provides a compound of formula (I) which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
|
|
WO/2001/095908A1 |
The present invention relates to protoberberine derivatives which inhibit the activity of mitogen-activated protein kinase. More specifically, the present invention is directed to protoberberine derivatives which inhibit the activity of ...
|
|
WO/2001/094351A1 |
This invention provides novel caspase inhibitors of formula I wherein R?1¿ is hydrogen, CHN¿2?, R, or -CH¿2?Y; R is an aliphatic group, an aryl group, an aralkyl group, a heterocyclyl group, or a heterocyclylalkyl group; Y is an elect...
|
|
WO/2001/085728A2 |
The present invention relates to optically pure 8-(substituted piperidino)-benzo [i,j] quinolizines, their isomers, derivatives, salts, pseudopolymorphs, polymorphs prodrugs and hydrates thereof, to processes for their preparation, and t...
|
|
WO/2001/079199A1 |
Acetylene derivatives represented by the general formula (I); and herbicides containing the derivatives and/or salts thereof as the active ingredient. In said formula R?1¿ to R?6¿, X?1¿, Y, Z and q are each as defined in the descripti...
|
|
WO/2001/079204A1 |
The invention relates to novel compounds of the formula (I) wherein W, X, Y, Z, G, A, B, Q?1¿, Q?2¿ and D are defined as per the description, to several methods for the production of said compounds and to their use as pesticides and he...
|
|
WO/2001/070734A2 |
The present application describes novel β-amino acid derivatives of formula (I) or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, U?a�, X?a�, Y?a�, Z?a�, R?1�, R?2�, R?3�, R?4�, and R?4a� a...
|
|
WO/2001/070739A1 |
The invention concerns compounds of general formula (I) wherein: X represents a hydrogen or halogen atom or an alkyl, alkoxy or trifluoromethyl group; and R represents either a hydrogen atom or an alkyl, cycloalkylmethyl, phenylmethyl gr...
|
|
WO/2001/042218A1 |
Quinoline derivatives represented by formula (1) wherein two or more of substituents R¿1 ?to R¿7? are each a group of formula (2). It is preferable that among the substituents R¿1? to R¿7?, at least one of the substituents other than...
|
|
WO/2001/029035A1 |
4-Oxoquinolizine antimicrobials having 2-pyridone skeletons as the partial structure and exhibiting potent antimicrobial activities against gram-positive or -negative bacteria or anaerobic bacteria, which are compounds represented by gen...
|
|
WO/2000/068229A2 |
The present invention relates to S-(-)-optically pure benzoquinolizine carboxylic acid of formula I, and their pharmaceutically acceptable salts, derivatives, pseudopolymorphs, and hydrates, substantially free of their R-(+)-isomers, to ...
|
|
WO/2000/066522A1 |
The present invention provides non-steroidal compounds of formula (I) which are selective modulators (i.e., agonists and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides p...
|
|
WO/2000/046223A1 |
Tricyclic quinolonecarboxylic acid derivatives represented by general formula (I) or salts thereof which are useful as remedies for skin infectious diseases, etc. showing a potent antibacterial effect on gram-positive and gram-negative b...
|
|
WO/2000/042045A2 |
The present invention is a novel series of functionalized heterocycles as chemokine receptor modulators of Formula (I) useful as modulators of chemokine receptor activity. The compounds are useful in the treatment and prevention of the A...
|
|
WO/2000/037468A1 |
The present invention provides a 5,6-dihydrodibenzo[a,g]quinolizinium derivative and the salts thereof of formula (I) which specifically inhibits the sterol 14-reductase which is involved in the distal pathway of cholesterol biosynthesis...
|
|
WO/2000/017197A1 |
The present invention comprises novel compounds that are effective inhibitors of integrins, particularly $g(a)¿IIb?$g(b)¿3? or $g(a)¿v? integrins such as $g(a)¿v?$g(b)¿3? and $g(a)¿v?$g(b)¿5?. The present invention, according to o...
|
|
WO/2000/008022A1 |
Compound of formula (I) or salts thereof or solvates thereof, in which, P is a single bond, methylene or ethylene; Q is hydrogen or C1-6alkyl; T is hydrogen; or Q and T together are -(CH¿2?)¿m?- wherein the saturated ring formed thereb...
|
|
WO/2000/008019A1 |
The present invention refers to a process for the preparation of (1$i(H))-benzo[c]quinolizin-3-ones derivatives of general formula (I) which involves only three steps and the use, as starting products, of commercially available, or easil...
|
|
WO/2000/008020A2 |
Compounds of formula (I) or salt thereof or solvate thereof, in which: m is 1 or 2; n is 1 or 2; X is CH or N; Y is selected from hydrogen, halogen, cyano, CF¿3?, alkyl or alkoxy; R?1¿, which may be at any position within the saturated...
|
|
WO/2000/006572A1 |
Benzoquinolizine derivatives having tachykinin antagonism, in particular, substance P receptor antagonism. Namely, benzoquinolizine derivatives represented by general formula (1) and salts thereof and medicinal compositions containing th...
|
|
WO/2000/006173A1 |
The present invention relates to a compound of formula (I); or a pharmaceutical acid addition salt thereof; which are useful for activating 5-HT¿1F? receptors and inhibiting neuronal protein extravasation in a mammal.
|
|
WO/2000/004905A1 |
Benzo[$i(b)]quinolizidine and benzo[$i(f)]indolizidine derivatives are provided which are useful for the treatment of Alzheimer's disease, senile dementia, or other conditions characterized by memory loss. Pharmaceutical compositions con...
|
